Suppr超能文献

专业连续血糖监测(pCGM)对初级保健中 2 型糖尿病患者血糖管理的影响。

Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care.

机构信息

International Diabetes Center at Park Nicollet, HealthPartners Institute, Minneapolis, MN, USA.

出版信息

J Diabetes Sci Technol. 2021 May;15(3):539-545. doi: 10.1177/1932296821998724. Epub 2021 Mar 10.

Abstract

BACKGROUND

Little data exists regarding the impact of continuous glucose monitoring (CGM) in the primary care management of type 2 diabetes (T2D). We initiated a quality improvement (QI) project in a large healthcare system to determine the effect of professional CGM (pCGM) on glucose management. We evaluated both an MD and RN/Certified Diabetes Care and Education Specialist (CDCES) Care Model.

METHODS

Participants with T2D for >1 yr., A1C ≥7.0% to <11.0%, managed with any T2D regimen and willing to use pCGM were included. Baseline A1C was collected and participants wore a pCGM (Libre Pro) for up to 2 weeks, followed by a visit with an MD or RN/CDCES to review CGM data including Ambulatory Glucose Profile (AGP) Report. Shared-decision making was used to modify lifestyle and medications. Clinic follow-up in 3 to 6 months included an A1C and, in a subset, a repeat pCGM.

RESULTS

Sixty-eight participants average age 61.6 years, average duration of T2D 15 years, mean A1C 8.8%, were identified. Pre to post pCGM lowered A1C from 8.8% ± 1.2% to 8.2% ± 1.3% (n=68, =0.006). The time in range (TIR) and time in hyperglycemia improved along with more hypoglycemia in the subset of 37 participants who wore a second pCGM. Glycemic improvement was due to lifestyle counseling (68% of participants) and intensification of therapy (65% of participants), rather than addition of medications.

CONCLUSIONS

Using pCGM in primary care, with an MD or RN/CDCES Care Model, is effective at lowering A1C, increasing TIR and reducing time in hyperglycemia without necessarily requiring additional medications.

摘要

背景

关于连续血糖监测(CGM)在 2 型糖尿病(T2D)的初级保健管理中的影响,数据很少。我们在一个大型医疗保健系统中启动了一个质量改进(QI)项目,以确定专业 CGM(pCGM)对血糖管理的影响。我们评估了 MD 和 RN/认证糖尿病护理和教育专家(CDCES)的护理模式。

方法

参与者患有 T2D 超过 1 年,A1C≥7.0%至<11.0%,使用任何 T2D 治疗方案且愿意使用 pCGM。收集基线 A1C,参与者佩戴 pCGM(Libre Pro)长达 2 周,然后由 MD 或 RN/CDCES 进行访问,以查看 CGM 数据,包括动态血糖图谱(AGP)报告。共同决策用于修改生活方式和药物治疗。3 至 6 个月的临床随访包括 A1C,在亚组中,重复使用 pCGM。

结果

68 名参与者平均年龄 61.6 岁,T2D 平均病程 15 年,平均 A1C 8.8%。与 pCGM 相关,A1C 从 8.8%±1.2%降至 8.2%±1.3%(n=68,=0.006)。在佩戴第二个 pCGM 的 37 名参与者中,TIR 和高血糖时间有所改善,同时低血糖时间也有所增加。血糖改善归因于生活方式咨询(68%的参与者)和治疗强化(65%的参与者),而不是添加药物。

结论

在初级保健中使用 pCGM,与 MD 或 RN/CDCES 护理模式相结合,可有效降低 A1C,增加 TIR,减少高血糖时间,而无需额外使用药物。

相似文献

引用本文的文献

3
7. Diabetes Technology: Standards of Care in Diabetes-2025.7. 糖尿病技术:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337/dc25-S007.
7
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.

本文引用的文献

3
7. Diabetes Technology: .7. 糖尿病技术:。
Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88. doi: 10.2337/dc20-S007.
4
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76. doi: 10.2337/dc20-S006.
6
Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016.2005 - 2016年美国糖尿病照护级联评估
JAMA Intern Med. 2019 Oct 1;179(10):1376-1385. doi: 10.1001/jamainternmed.2019.2396.
9
A View Beyond HbA1c: Role of Continuous Glucose Monitoring.糖化血红蛋白之外的视角:持续葡萄糖监测的作用
Diabetes Ther. 2019 Jun;10(3):853-863. doi: 10.1007/s13300-019-0619-1. Epub 2019 Apr 29.
10
7. Diabetes Technology: .7. 糖尿病技术: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80. doi: 10.2337/dc19-S007.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验